University of Queensland
Microba is a microbial genomics company originating from technology developed at the University of Queensland. It has quickly established itself as a world leader in the analysis of the gut microbiome. With a growing body of global research indicating that the gut microbiome plays a central role in health and disease, Microba has quickly positioned itself to be a leading force in the development of new pathology services, therapeutics and diagnostics based on the microbiome.
Utilising Microba’s proprietary Metagenomic Analysis Platform (MAP), a bioinformatic data analysis pipeline, Microba has delivered its comprehensive gut microbiome analysis service to over 7000 consumers, researchers and healthcare practitioners. Working alongside leading healthcare professionals, Microba is developing new pathology services to enable microbiome testing to become a part of routine clinical care.